insights_auto
Why is NXTCL down 6.09%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0.96
arrow_downward
-6.09%(-0.062) 1D
Oct 16, 5:08:13 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.99
High
SEK 1.00
Low
SEK 0.94
Mkt. cap
120.83M
Avg. vol.
369.66K
Volume
0.00
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEK 0.99
High
SEK 1.00
Low
SEK 0.94
Mkt. cap
120.83M
Avg. vol.
369.66K
Volume
0.00
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Opening Bell Daily
·
1 hour ago
Stock market after midterms: S&P 500 up all 19 times
FinanceFeeds
·
1 hour ago
The Nasdaq Index Just Had Its Worst Week Since June - and Netflix, Tesla and Meta Report Next
Yahoo Finance
·
11 hours ago
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
1 day ago
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorBiotechnology
Websitenextcellpharma.com